2 domains / 4 areas / 3 specializations
Pharmaceutical Benefits Advisory Committee (PBAC)
Data updated
Australia’s HTA and reimbursement advisory body for PBS listing decisions, including esketamine (Spravato) assessment materials.
Reimbursement & Market Access Snapshot
Health EconomistsService Model
Public Payer / National Coverage Authority
Jurisdiction
National
Coverage
1 country
Last Verified
Apr 8, 2026
Focus Areas
Evidence Requirements
Market Access Notes
PBAC forms recommendations underpinning PBS listing decisions and publishes medicine-status updates that include esketamine-related records.
Verification
Verified
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement Status
Active
Public Sector Governance Snapshot
Health Technology Assessment AgenciesAuthority Type
Health Technology Assessment Agency
Jurisdiction
National
Coverage
1 country
Framework Status
Active
Function Areas
Governance Notes
Wave 5 L3 completion pass for Pharmaceutical Benefits Advisory Committee (PBAC).
Verification
Verified
Psychedelic Engagement
Psychedelic-Adjacent Focus
Last Verified
Apr 16, 2026
Verification Notes
PBAC process and PBS esketamine listing support adjacent psychedelic-governance categorization.
Policy Instruments
Quick Facts
- Website
- Visit